Tag: Irritable Bowel Syndrome

TrIuMPH: Investigational agent for IBS plus constipation shows potential

Presented By
Prof. Anthony Hobson, Functional Gut Clinic, UK
Trial
Phase 2, TrIuMPH
Conference
DDW 2025
Type
News article

21 May 2025 11:23

Guar gum alleviates IBS-related constipation in a randomised controlled trial

Presented By
Dr Silvia Delgado-Aros, Nestle Health Sciences, Switzerland
Conference
UEGW 2024
Type
Peer-reviewed article

28 November 2024 11:20

Hormone-containing therapies may increase the risk of IBS and functional dyspepsia

Presented By
Dr Michael Jones, Macquarie University, Australia
Conference
DDW 2024
Type
Peer-reviewed article

11 July 2024 11:15

DIVERSITY1: Filgotinib results in Crohn’s disease leave investigators puzzled

Presented By
Prof. Séverine Vermeire, UZ Leuven, Belgium
Trial
Phase 3, DESTINY1
Conference
UEGW 2023
Type
Peer-reviewed article

7 December 2023 15:48

SEQUENCE: Risankizumab doubles endoscopic remission rates compared with ustekinumab in CD

Presented By
Prof. Laurent Peyrin-Biroulet, University Hospital of Nancy, France
Trial
Phase 3, SEQUENCE
Conference
UEGW 2023
Type
Peer-reviewed article

7 December 2023 15:44

Guselkumab provides benefits in UC regardless of advanced therapy history

Presented By
Prof. Axel Dignass, Goethe University, Germany
Trial
Phase 3, QUASAR
Conference
UEGW 2023
Type
Peer-reviewed article

7 December 2023 15:42

INSPIRE: Risankizumab meets all efficacy endpoints in UC

Presented By
Prof. Edouard Louis, Liège University Hospital, Belgium
Trial
Phase 3, INSPIRE
Conference
UEGW 2023
Type
Peer-reviewed article

7 December 2023 15:39

Risankizumab resolves extraintestinal manifestations in CD

Presented By
Prof. Subrata Ghosh, Cork University College, Ireland
Trial
Phase 3, ADVANCE; MOTIVATE; FORTIFY
Conference
UEGW 2023
Type
Peer-reviewed article

7 December 2023 15:36

Obefazimod takes the spotlight as promising UC treatment

Presented By
Prof. Séverine Vermeire, UZ Leuven, Belgium
Trial
Phase 2
Conference
UEGW 2023
Type
Peer-reviewed article

7 December 2023 15:32

Rapid response to upadacitinib boosts outcomes in severe Crohn’s disease

Presented By
Prof. Jean-Frederic Colombel, Icahn School of Medicine at Mount Sinai, NY, USA
Trial
Phase 3, U-EXCEED; U-EXCEL
Conference
UEGW 2023
Type
Peer-reviewed article

7 December 2023 15:27

Digital intervention relieves symptoms and improves QoL in IBS

Presented By
Ms Linda WeiĂźer, HiDoc Technologies GmbH, Germany
Conference
UEGW 2023
Type
Peer-reviewed article

7 December 2023 14:18

IBS management: the complex role of dietary fibres

Presented By
Dr Jose Maria Remes-Troche, Veracruzana University, Mexico
Conference
DDW 2023
Type
News article

13 June 2023 13:45

A pragmatic guide to the updated IBS guidelines

Expert
Nottingham University Hospital, UK
Conference
ECNP2021
Type
Peer-reviewed article

26 November 2021 10:47

Plecanatide effective for IBS with constipation

Presented By
Prof. Eamonn M. Quigley, Houston Methodist Hospital, TX, USA
Conference
UEGW 2020
Type
News article

2 November 2020 11:46

Sustained response to faecal microbiota transplantation

Presented By
Prof. Magdy El-Salhy, University of Bergen, Norway
Conference
UEGW 2020
Type
News article

2 November 2020 11:39

Faecal microbiota transplantation is effective for irritable bowel syndrome

Presented By
Prof. Magdy El-Salhy, Haukeland University Hospital, Norway
Conference
UEGW 2019
Type
Peer-reviewed article

23 October 2019 20:38

Plant-based foods and Mediterranean diet associated with healthy gut microbiome

Presented By
Laura Bolte, University Medical Center Groningen, the Netherlands
Conference
UEGW 2019
Type
Peer-reviewed article

23 October 2019 19:59

Half of common medications wreak havoc on gut microbiome

Conference
UEGW 2019
Type
Peer-reviewed article

23 October 2019 18:14

Human milk oligosaccharides improve IBS symptoms

Presented By
Dr Olafur Palsson, Chapel Hill, North Carolina, USA
Conference
UEGW 2019
Type
Peer-reviewed article

23 October 2019 15:30
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com